C-ANCA measurement

Schmitt WH & van der Woude FJ: Clinical applications of antineutrophil cytoplasmic antibody testing. Curr Opin Rheumatol 2004; 16:9-17. Available from URL: http://www.medscape.com/viewarticle/467031. As accessed January 6, 2005.

Booth AD, Almond MK, Burns A, et al: Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41:776-784.

Gal AA & Velasquez A: Antineutrophil cytoplasmic autoantibody in the absence of wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist. Mod Pathol 2002; 15:197-204.

Csernok E, Holle J, Hellmich B, et al: Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in wegener's granulomatosis: first results from a multicentre study. Rheumatology 2004; 43:174-180.

Stone JH, Talor M, Stebbing J, et al: Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 2000; 13:424-434.

Merkel PA, Polisson RP, Chang YC, et al: Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997; 126:866-873.

Savige J, Dimech W, Fritzler M, et al: Addendum to the international consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 2003; 120:312-318.

Savige J, Gillis D, & Benson E: International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999; 111:507-513.